Search Results 481-490 of 16342 for anti-TNF drugs
Rituximab is now established as an effective drug for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis following major European and US trials reported in ...
On the immune system side, the number of experimental treatments is growing. The vast majority are called monoclonal antibodies. This type of drug is not new, ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
... anti-HER2 agents would provide more benefit compared to single anti-HER2 therapy.” Dr. Perez added that the findings were additionally disappointing in that ...
The purpose of this study is to evaluate the safety and effectiveness of a treatment of Atezolizumab (MPDL3280A) combined with carboplatin, paclitaxel, and with ...
A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC ... A Study of the Drugs Selumetinib vs. Carboplatin ...
Treatment with an anti-complement therapy or with Zileuton (Zyflo) within the last three months prior to baseline (Day 1). OCS dose no more than 0.3mg/kg ...
The practice involves physicians prescribing medications for the treatment ... Health care providers and patients should educate themselves about off-label drugs ...
Treatment options vary, as well, with surgery, chemotherapy and nuclear medicine therapy among the options. Once he had a diagnosis, Elsten had clarity. “I was ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.